Shandong Shengli Bioengineering Co., Ltd

Shandong Shengli Bioengineering Co., Ltd (Abbreviation: SHENGLI) is a joint venture built by China Animal Husbandry Industry Company Limited (Abbreviation: CAHIC) and Shandong Shengli Corporation Limited. And originally built in 2004 with total investment of RMB 500 million, and guided by bio-fermentation technology, producing animal-specific antibiotic API, veterinary preparations and feed additives. Also, it is national high-tech enterprise, and regarded as top 10 veterinary drug enterprise in Shandong province and top 10 in national veterinary drug industry in China. Shengli is located in No.118, High-tech zone, Jining city, Shandong province, China. And it has covered an area of 70 acres, and equipped with 1st class facility as well as advanced management. Currently Shengli primarily manufactures feed additives, such as Enramycin, Bambermycin, Hainanmycin, Nosiheptide, Monensin and Salinomycin, also veterinary drugs as Tiamulin Fumarate, Florfenicol, Tilmicosin, Doxycycline Hydroc…